Trends in blood utilization in United States cardiac surgical patients

Transfusion

Volumn 55, Issue 4, 2015, Pages 805-814

  Robich, Michael P ^a   Koch, Colleen G ^a   Johnston, Douglas R ^a   Schiltz, Nicholas ^b   Chandran Pillai, Aiswarya ^b   Hussain, Syed T ^a   Soltesz, Edward G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

ADULT; AGED; ANEMIA; AORTA ANEURYSM; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; BLOOD CONSERVATION; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ENDOVASCULAR ANEURYSM REPAIR; ERYTHROCYTE TRANSFUSION; FEMALE; HEART FAILURE; HEART SURGERY; HEART VALVE SURGERY; HUMAN; KIDNEY FAILURE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RISK FACTOR; UNITED STATES; BLOOD COAGULATION DISORDERS; BLOOD SALVAGE; COMORBIDITY; HEART DISEASES; HOSPITAL; HOSPITAL BED CAPACITY; HYPERTENSION; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; OBESITY; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION;

ANEMIA; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; COMORBIDITY; DIABETES MELLITUS; FEMALE; GUIDELINE ADHERENCE; HEART DISEASES; HOSPITAL BED CAPACITY; HOSPITALS; HUMANS; HYPERTENSION; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; MALE; OBESITY; OPERATIVE BLOOD SALVAGE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; UNITED STATES;

EID: 84926435726     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12903     Document Type: Article

References (29)

1. Sullivan MT, Cotten R, Read EJ, et al. Blood collection and transfusion in the United States in 2001. Transfusion 2007; 47: 385-394.
2. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010; 304: 1568-1575.
3. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with RBC and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608-1616.
4. Walkden GJ, Verheyden V, Goudie R, et al. Increased perioperative mortality following aprotinin withdrawal: a real-world analysis of blood management strategies in adult cardiac surgery. Intensive Care Med 2013; 39: 1808-1817.
5. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239.
6. Shander A,. Financial and clinical outcomes associated with surgical bleeding complications. Surgery 2007; 142 (4 Suppl): S20-25.
7. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83 (5 Suppl): S27-86.
8. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-982.
9. Wang G, Bainbridge D, Martin J, et al. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109: 320-330.
10. Healthcare Cost and Utilization Project (HCUP). Clinical Classifications Software (CCS) for ICD-9-CM. Agency for Healthcare Research and Quality, Rockville, Maryland. 2013. [cited 2014 Oct 18]. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.
11. Pettersson GB, Martino D, Blackstone EH, et al. Advising complex patients who require complex heart operations. J Thorac Cardiovasc Surg 2013; 145: 1159-1169.e3.
12. Siracuse JJ, Robich MP, Gautam S, et al. Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage. Surgery 2010; 148: 724-729; discussion 729-30.
13. Fitchett D, Mazer CD, Eikelboom J, et al. Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implications. Can J Cardiol 2013; 29: 1042-1047.
14. Leong JY, Baker RA, Shah PJ, et al. Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg 2005; 80: 928-933.
15. Sedrakyan A, Treasure T, Elefteriades JA,. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004; 128: 442-448.
16. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-2331.
17. Schneeweiss S, Seeger JD, Landon J, et al. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008; 358: 771-783.
18. Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med 2008; 358: 784-793.
19. Dietrich W, Spannagl M, Boehm J, et al. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Anesth Analg 2008; 107: 1469-1478.
20. Likosky DS, FitzGerald DC, Groom RC, et al. Effect of the perioperative blood transfusion and blood conservation in cardiac surgery clinical practice guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. Anesth Analg 2010; 111: 316-323.
21. Brevig J, McDonald J, Zelinka ES, et al. Blood transfusion reduction in cardiac surgery: multidisciplinary approach at a community hospital. Ann Thorac Surg 2009; 87: 532-539.
22. Koch CG, Li L, Hixson E, et al. What are the real rates of postoperative complications: elucidating inconsistencies between administrative and clinical data sources. J Am Coll Surg 2012; 214: 798-805.
23. Segal JB, Ness PM, Powe NR,. Validating billing data for RBC transfusions: a brief report. Transfusion 2001; 41: 530-533.
24. Cosgrove DM, Loop FD, Lytle BW, et al. Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg 1985; 40: 380-384.
25. Jin R, Zelinka ES, McDonald J, et al. Effect of hospital culture on blood transfusion in cardiac procedures. Ann Thorac Surg 2013; 95: 1269-1274.
26. Karkouti K, von Heymann C, Jespersen CM, et al. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. J Thorac Cardiovasc Surg 2013; 146: 927-939.
27. LaPar DJ, Crosby IK, Ailawadi G, et al. Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg 2013; 145: 796-803; discussion 803-4.
28. Department of Health & Human Services. The 2011 national blood collection and utilization survey report. Rockville (MD): Department of Health & Human Services; 2011.
29. Belway D, Rubens FD, Wozny D, et al. Are we doing everything we can to conserve blood during bypass? A national survey. Perfusion 2005; 20: 237-241.